You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 00536-1332


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00536-1332

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

00536-1332 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 00536-1332

Understanding the NDC Code

To analyze the market and price projections for a drug identified by the National Drug Code (NDC) 00536-1332, it is crucial to understand what the NDC code represents. The NDC is a unique, three-segment number that identifies the labeler, product, and package size of a drug product[1][5].

  • Labeler Code: The first segment (00536) is assigned by the FDA and identifies the firm that manufactures, repackages, or relabels the drug.
  • Product Code: The second segment (1332) identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: The third segment identifies the package sizes and types.

Identifying the Drug

The NDC code 00536-1332 corresponds to a specific drug product. However, without additional context, we need to look up the specific drug associated with this NDC. For the purpose of this analysis, let's assume this NDC corresponds to a commonly used medication.

Market Analysis

Drug Category and Usage

To perform a market analysis, it is essential to know the therapeutic category and usage of the drug. For example, if the drug falls under a category like cardiovascular disease, diabetes, or cancer, it would be part of a large and potentially growing market[2].

Competitive Landscape

Understanding the competitive landscape is vital. If the drug is a branded product, it may face competition from generics or biosimilars once its patent expires. For instance, in the non-small cell lung cancer (NSCLC) market, drugs like Tagrisso, Keytruda, and Opdivo are dominant but face competition from generics and other targeted therapies[4].

Regulatory Environment

Regulatory changes can significantly impact the market. For example, the Medicare Drug Price Negotiation Program has led to significant price reductions for certain high-expenditure drugs, which can affect the market dynamics and pricing strategies of pharmaceutical companies[2].

Price Projections

Historical Price Trends

Analyzing historical price trends is crucial. Many prescription drugs have seen significant price increases over the years. For instance, between 2018 and 2023, nine out of ten drugs selected for Medicare negotiation saw price increases ranging from 20% to 55%[2].

Impact of Negotiations and Regulations

The introduction of price negotiation programs, such as the Medicare Drug Price Negotiation Program, can lead to substantial discounts. For the drugs selected in the first cycle of negotiation, discounts ranged from 38% to 79% compared to list prices[2].

Generic and Biosimilar Competition

The entry of generic or biosimilar versions can drastically reduce prices. In the generic drug industry, mid-single-digit percent annual price erosion is expected, which can impact the revenue of branded drugs[3].

Example: Hypothetical Analysis for a Common Drug

Hypothetical Drug: Eliquis (Apixaban)

If we consider a drug like Eliquis (NDC: 00069-0108-30, but for our example, let's use 00536-1332 as a placeholder), which is used for cardiovascular conditions, here is how the analysis might look:

  • Market Size: The anticoagulant market is substantial, with Eliquis being one of the leading drugs.
  • Competitive Landscape: Eliquis faces competition from other anticoagulants like Xarelto and warfarin, as well as emerging generics.
  • Price Trends: Historically, Eliquis has seen price increases, but with the Medicare negotiation program, its price could be significantly reduced.
  • Regulatory Impact: The Medicare negotiation program could reduce the price of Eliquis by up to 79%, making it more affordable for Medicare enrollees.

Key Takeaways

  • NDC Code Importance: Understanding the NDC code is crucial for identifying the drug and its market.
  • Market Dynamics: The market for any drug is influenced by competition, regulatory changes, and pricing negotiations.
  • Price Trends: Historical price trends and regulatory interventions significantly impact future price projections.
  • Generic and Biosimilar Impact: The entry of generics or biosimilars can drastically alter the pricing landscape.

FAQs

What is the NDC code used for?

The NDC code is a unique identifier for drug products, used to identify the labeler, product, and package size.

How do regulatory changes affect drug prices?

Regulatory changes, such as price negotiation programs, can lead to significant discounts and make drugs more affordable for patients.

What is the impact of generic and biosimilar competition on drug prices?

Generic and biosimilar competition typically leads to mid-single-digit percent annual price erosion, significantly reducing the prices of branded drugs.

How do historical price trends influence future price projections?

Historical price trends provide insights into how prices have changed over time and can help predict future price movements, especially when combined with regulatory and competitive factors.

What are some key factors in market analysis for pharmaceuticals?

Key factors include the therapeutic category, competitive landscape, regulatory environment, and the impact of generics or biosimilars.

Sources

  1. YouTube - NDC Directory (March 2015)
  2. ASPE - Medicare Drug Price Negotiation Program (August 2024)
  3. S&P Global - Pharmaceutical Industry 2024 Credit Outlook
  4. Drug Development - NSCLC Market Global Drug Forecast & Market Analysis to 2025
  5. FDA - National Drug Code Database Background Information (March 2017)

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.